Skip to main content
Article thumbnail
Location of Repository

IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay

By Morten Ruhwald, Morten Bjerregaard-Andersen, Paulo Rabna, Jesper Eugen-Olsen and Pernille Ravn
Topics: Short Report
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2660909
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2005). al.: IFNgamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect
    2. (2003). Chang JH: Changes of plasma interleukin-1 receptor antagonist, interleukin-8 and other serologic markers during chemotherapy in patients with active pulmonary tuberculosis.
    3. (2001). Colston MJ: Changes in gene expression in macrophages infected with Mycobacterium tuberculosis: a combined transcriptomic and proteomic approach. Immunology
    4. (1999). Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIVseronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan. Infect Immun
    5. (2007). et al.: Comparison of an Interferon-{gamma} Release Assay with Tuberculin Skin Testing in HIV-infected Individuals. Am J Respir Crit Care Med
    6. (2007). et al.: Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment. Infection
    7. (2006). et al.: Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet
    8. (2008). Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of TB. Eur Respir J
    9. (1996). Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1.
    10. (2008). Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS ONE
    11. (2007). Meta-analysis: New Tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for Research. Ann Intern Med
    12. (2003). Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies. Microcirculation
    13. (2003). Monocyte chemotactic protein-1 production in patients with active pulmonary tuberculosis and tuberculous pleurisy. Inflamm Res
    14. (2007). Ravn P: IP-10/CXCL10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect
    15. (2006). Ravn P: Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir Res
    16. (2006). Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis.
    17. (2008). Systematic Review: T-Cell-based Assays for the Diagnosis of Latent Tuberculosis Infection: An Update. Ann Intern Med
    18. (2007). The prognosis of latent tuberculosis: can disease be predicted? Trends in Molecular Medicine
    19. (2001). Tsicopoulos A, et al.: Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.